Join our LinkedIn PATENTSCOPE users Community Group
Feedback
Settings

Settings

Goto Application

84,410 results
Offices all Languages Stemming true Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K33/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 8,441
1.WO/2024/094112SELENIUM-CONTAINING SUBSTANCE FOR TREATMENT OF CANCER
WO - 10.05.2024
Int.Class A61K 31/095
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
095Sulfur, selenium or tellurium compounds, e.g. thiols
 Appl.No PCT/CN2023/129292 Applicant SHANGHAI INSTITUTE OF NUTRITION AND HEALTH, CHINESE ACADEMY OF SCIENCES Inventor ZHAN, Lixing
The present invention relates to a selenium-containing substance for the treatment of cancer. Specifically, the present invention provides use of a seleno-amino acid for preparing a composition or a preparation. The composition or the preparation is used for preventing and/or treating cancer. It is found for the first time in the present invention that the seleno-amino acid can effectively prevent and/or treat cancer.
2.WO/2024/092327COMPOSITION FOR OBTAINING A NATURAL BIOACTIVE COMPOUND FOR CANCER TREATMENT
WO - 10.05.2024
Int.Class A61K 36/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
19Acanthaceae (Acanthus family)
 Appl.No PCT/BR2022/050473 Applicant MEY, Angelica Machado Inventor LAISO, Rosa Andrea Nogueira
The present invention relates to a composition for obtaining a natural bioactive compound for cancer treatment, based on Andrographis paniculata, with phosphorylethanolamine as an excipient and, optionally, carbonates. The composition aims to aid in the treatment of numerous types of cancer, and can be administered as an auxiliary adjuvant in cancer treatments. Since the main bioactive components of said composition are diterpenoids, flavonoids and polyphenols, said composition has anti-inflammatory, antiviral, antibacterial, antioxidant, antiparasitic, antispasmodic, antidiabetic, antipyretic, nematicidal, immunomodulatory and immunostimulatory properties. The composition for obtaining a natural bioactive compound for cancer treatment comprises: Andrographis paniculata as an active ingredient; and phosphorylethanolamine as an excipient. Optionally, the excipients may include: phosphorylethanolamine, calcium carbonate and magnesium carbonate.
3.WO/2024/097601METHOD OF REDUCING LAMENESS AND IMPROVING BONE MINERALIZATION IN SWINE
WO - 10.05.2024
Int.Class A23K 20/24
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
KFEEDING-STUFFS SPECIALLY ADAPTED FOR ANIMALS; METHODS SPECIALLY ADAPTED FOR PRODUCTION THEREOF
20Accessory food factors for animal feeding-stuffs
20Inorganic substances, e.g. oligo-elements
24Compounds of alkaline earth metals, e.g. magnesium
 Appl.No PCT/US2023/077994 Applicant CAN TECHNOLOGIES, INC. Inventor DECOUX, Marc Guillaume Ionam David
The present technology provides a method for feeding swine, the method includes: feeding swine a swine feed that includes a nitrate compound, hydrates thereof, salts thereof, or combinations thereof, and optionally an antioxidant that includes polyphenols; wherein the method increases bone mineral deposition and/or reduces the occurrence of joint lesions in swine fed the swine feed compared to a control swine not fed the nitrate compounds, hydrates thereof, salts thereof.
4.WO/2024/092369FERTILITY ENHANCEMENT COMPOSITION
WO - 10.05.2024
Int.Class A61K 36/82
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
82Theaceae (Tea family), e.g. camellia
 Appl.No PCT/CA2023/051474 Applicant EXERKINE CORPORATION Inventor TARNOPOLSKY, Mark
A method for promoting fertility enhancement in a mammal is provided, comprising administering to the mammal a weight loss agent, a mitochondria-enhancing agent and a fertility support agent. Compositions for fertility enhancement are also provided.
5.20240148761Chelated Metal Oxide Cannabinoid Gel Composition
US - 09.05.2024
Int.Class A61K 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
 Appl.No 18387007 Applicant William Wingfield Inventor William Wingfield

A homogeneous gel composition for topical wound treatment and other healthcare purposes. Said gel composition comprising a cationic chelated chitosan-silver gel incorporating at least one cannabinoid and having antimicrobial, antibacterial, anti-inflammatory and/or analgesic properties. A method for treating a wound or skin disorder using the gel composition is also disclosed.

6.20240148783FORMULATION, USE AND METHOD FOR BROAD-SPECTRUM PROPHYLAXIS AND TREATMENT OF VIRAL INFECTIONS CAUSED BY SARS-COV-2 AND OTHER EMERGENT VIRUSES
US - 09.05.2024
Int.Class A61K 33/30
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
30Zinc; Compounds thereof
 Appl.No 18388618 Applicant MELISA INSTITUTE, GENOMICS & PROTEOMICS RESEARCH S Inventor Elard KOCH

EGCG-Zn2+ molecular complexes exhibit a significantly higher affinity than the EGCG molecule alone or Zn2+ alone for binding to different SARS-CoV-2 molecular targets and show virtually complete antiviral suppressive activity (>99%) against this virus in experimental models of infection. EGCG-Zn2+ complexes have a lower toxicity than EGCG alone in transfected human cells. The combination of EGCG and Zn2+, significantly improved some key pharmacokinetic parameters of EGCG in humans. Thus, these complexes can be used as a new broad-spectrum method for chemoprophylaxis or treatment of viral diseases by using formulations containing a composition of EGCG and Zn2+ or EGCG-Zn2+ complexes in sufficient amount to reach a blood concentration with antiviral effect, minimizing safety issues in humans.

7.20240148962INTRAVENOUS DELIVERY OF LARGE VOLUMES OF GAS WITH HIGHLY PRESSURIZED SUPERSATURATED SOLUTION
US - 09.05.2024
Int.Class A61M 5/14
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
5Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
14Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
 Appl.No 18548814 Applicant Regents of the University of Minnesota Inventor Demetris Yannopoulos

An example system includes a fluid delivery device configured to deliver gas nanobubbles to a target site of a patient from a solution comprising a fluid, supersaturated with a. gas, wherein the fluid delivery' device defines a flow channel configured to flow the solution through the flow channel such that the gas in the supersaturated fluid forms gas nanobubbles as the solution flows through the flow channel towards the target site, and wherein the gas nanobubbles remain in the fluid at least until delivery' to the target site.

8.202023100002Pharmazeutisches Präparat zur Bekämpfung der Vermehrung und Verbreitung von Influenzaviren
DE - 08.05.2024
Int.Class A61K 33/20
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
20Elemental chlorine; Inorganic compounds releasing chlorine
 Appl.No 202023100002 Applicant Flamina Holding AG Inventor

Pharmazeutisches Präparat (1) zur Verhinderung der Vermehrung und Ausbreitung von Influenzaviren, insbesondere von Influenzaviren der Covid-Spezies und deren Mutationen, mit einem für den Anwender pharmazeutisch verträglichen Träger (10), dem Aromastoffe sowie mindestens eine erste viruzide Komponente (11) in einer Konzentration beigefügt ist, die nach der oralen Einnahme des Präparats (1) und der Aktivierung eine antivirale Wirkung entfaltet und für den Anwender verträglich ist, dadurch gekennzeichnet, dass die erste viruzide Komponente (11) Natriumchlorit ist, das nach der Einnahme des pharmazeutischen Präparats (1) im Speichel des Anwenders in Chlordioxid umgewandelt wird. embedded image

9.11975021Topical compositions comprising emulsified povidone iodine solutions and methods of preparation
US - 07.05.2024
Int.Class A61K 33/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
18Iodine; Compounds thereof
 Appl.No 18378069 Applicant James Kojian Inventor James Kojian

Compositions for treating inflammatory skin conditions are described. The compositions can include povidone iodine in aqueous solution, hydrocortisone, diphenhydramine, an emulsifier, and a hydrophobic carrier, where the povidone iodine aqueous solution is emulsified in the hydrophobic carrier. A method of preparing a composition is also described. The method can include adding an aqueous solution of povidone iodine to a hydrophobic carrier, and adding an emulsifier to the hydrophobic carrier at a concentration that emulsifies the aqueous solution of povidone iodine in the hydrophobic carrier upon mixing.

10.202024100973Formulierung und System zur Synthese von Chitosan-vermittelten Li 1.5 I Fe 1.5 III O 3 Nanokomposit
DE - 02.05.2024
Int.Class A61K 33/26
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
26Iron; Compounds thereof
 Appl.No 202024100973 Applicant Delekar Sagar Dadu Inventor

Eine Formulierung zur Synthese von Chitosan-vermittelten Li 1.5 I Fe 1.5 III O 3 Nanokompositen, umfassend: eine wirksame Menge Eisennitrat [ Fe( NO 3) 3 ·9H 2 O, 98.00 %]; eine wirksame Menge Lithiumnitrat [Li (NO 3) 2 6H 2 O, 99.99 %]; eine wirksame Menge Chitosan (CTS)-Biopolymer [(C6H 11 NO4)n , 90 % deacetyliert]; eine wirksame Menge Zitronensäure; eine wirksame Menge Salpetersäure; und eine wirksame Menge Ammoniumhydroxidlösung. embedded image

# -